Last reviewed · How we verify
Vitamin D: solid form, start weekly
Vitamin D acts as a steroid hormone precursor that regulates calcium and phosphate homeostasis, immune function, and cellular differentiation.
Vitamin D acts as a steroid hormone precursor that regulates calcium and phosphate homeostasis, immune function, and cellular differentiation. Used for Vitamin D deficiency, Hypocalcemia, Osteoporosis prevention and treatment.
At a glance
| Generic name | Vitamin D: solid form, start weekly |
|---|---|
| Also known as | Dekristolvit D3 |
| Sponsor | University Hospital, Basel, Switzerland |
| Drug class | Vitamin/Steroid hormone |
| Target | Vitamin D receptor (VDR) |
| Modality | Small molecule |
| Therapeutic area | Endocrinology, Bone Health, Immunology |
| Phase | FDA-approved |
Mechanism of action
Vitamin D is converted in the liver and kidneys to its active form, calcitriol, which binds to the vitamin D receptor (VDR) in target tissues. This modulates gene expression to promote intestinal calcium absorption, bone mineralization, immune regulation, and cell proliferation control. It is essential for maintaining serum calcium and phosphate levels and supporting overall skeletal and systemic health.
Approved indications
- Vitamin D deficiency
- Hypocalcemia
- Osteoporosis prevention and treatment
- Secondary hyperparathyroidism
Common side effects
- Hypercalcemia
- Hypercalciuria
- Nausea
- Constipation
- Weakness
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: